D.E. Shaw & Co
CABA icon

D.E. Shaw & Co’s Cabaletta Bio CABA Stock Holding History

D.E. Shaw & Co’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
90,652
-98,760
-52% -$325K ﹤0.01% 4439
2026
Q1 		$510K Buy
+189,412
New +$526K ﹤0.01% 3851
2025
Q1 		– Sell
-16,604
Closed -$37.7K – 4283
2024
Q4 		$37.7K Sell
16,604
-17,359
-51% -$60.9K ﹤0.01% 4210
2024
Q3 		$160K Buy
+33,963
New +$197K ﹤0.01% 4194
2024
Q2 		– Sell
-16,111
Closed -$275K – 4502
2024
Q1 		$275K Buy
+16,111
New +$346K ﹤0.01% 3777

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

D.E. Shaw & Co's CABA Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Cabaletta Bio (CABA) stake by 52% in Q2 2026, selling an estimated $325K and leaving 90,652 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #4439.

D.E. Shaw & Co first reported a position in CABA in Q1 2024 and has held it in 5 quarters since. The position peaked at $510K in Q1 2026. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • D.E. Shaw & Co held 90,652 shares of Cabaletta Bio worth $282K as of Q2 2026.
  • D.E. Shaw & Co sold 98,760 Cabaletta Bio shares in Q2 2026, an estimated $325K.
  • Cabaletta Bio made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4439 holding.
  • D.E. Shaw & Co first reported a position in Cabaletta Bio in Q1 2024 and has held it in 5 quarters since.
  • D.E. Shaw & Co's Cabaletta Bio position peaked at $510K in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.